AAVANTGARDE BIO
#9122 COMPANY RANKING
AAVantgarde Bio is a clinical-stage biotechnology company specializing in developing gene therapies for inherited retinal disorders. Founded in 2021, the company leverages proprietary AAV vector platforms to address gene therapy cargo capacity limitations, aiming to deliver treatments for conditions like Stargardt disease and Usher syndrome type 1B.
Claim This Company
#9122
Ranking Index(All Ranking)0%
Grow & Performance(seo & stats)0
Traffic(Website, visiotrs & user retention)- Company Ranking
AAVANTGARDE BIO
5D1M6Mmax





Worth



